#China #Beijing #Fosun Pharma #Sisram Medical #Sinmait Technology

Sisram Medical Partners with Sinmait Medical Technology to Build a New Manufacturing and Innovation Hub in China

In a remarkable move that signals a new chapter in medical aesthetics, Sisram Medical Ltd., a key player in wellness technologies, has signed a memorandum of understanding with Sinmait Medical Technology (Beijing) Co., Ltd. This collaboration aims to enhance the localization of their production efforts within China, thereby meeting the growing domestic demands for medical aesthetic solutions.

Accelerating Strategic Growth

Sisram Medical, traded as 1696.HK, has been a pioneer in Energy-Based Devices (EBD) and injectables for over 25 years. With its recent partnership with Sinmait, a subsidiary of the Shanghai Fosun Pharmaceutical Group, Sisram is poised to accelerate its business expansion in the burgeoning Chinese market. This agreement not only strengthens their supply chain but also bolsters their competitive edge in the medical aesthetics arena.

Establishing a Robust Manufacturing Hub

The partnership sets the stage for the establishment of an innovative manufacturing hub that will focus initially on the localized production of Energy-Based Devices. This strategic center aims to cater to increasing local demand while also supporting the broader Asia-Pacific (APAC) region. With this facility, Sisram will be able to streamline logistics and amplify research and development efforts, ultimately enhancing their product portfolio to accommodate a diverse set of consumer needs.

Chairman and Executive Director, Lior Dayan, commented on the significance of the partnership, stating, "This collaboration elevates our localization strategy in China and lays the foundation for sustainable growth. Our vision of 'In China, for Global' will help us deliver superior wellness solutions to Chinese consumers."

Meeting the Growing Demand

As the trend of combined therapies gains momentum in China's aesthetic sector, this partnership is timely. By embedding localized production capabilities alongside their existing offerings, Sisram is positioned not only to enhance its product effectiveness but also to increase accessibility for consumers seeking high-quality wellness solutions.

A Legacy of Innovation

Sisram Medical has built a legacy upon clinical excellence and technological advancements. Their commitment to enhancing aesthetic care through safe and effective solutions has won them accolades globally. With operations currently spanning over 110 countries, this partnership with Sinmait sigifies another leap forward in their mission to set new standards in medical aesthetics.

This cooperative venture with Fosun Pharma indicates Sisram's strategic intent to innovate in the local market, leveraging Sinmait's advanced production capabilities to achieve this goal. Overall, the collaboration aims to facilitate scalable production while retaining a competitive edge locally and globally.

Conclusion

As Sisram Medical embarks on this ambitious journey in collaboration with Sinmait Medical Technology, the establishment of this localized manufacturing hub marks a forward-thinking approach to enhancing the wellness landscape in China. With a focus on quality, accessibility, and innovation, Sisram is set to redefine the standards of aesthetic care for millions of consumers worldwide.